Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Almitrine in COVID-19-related Hypoxemic Respiratory Failure (AIRVM-COVID)
NCT04357457Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of almitrine in coronavirus disease 2019 (COVID-19), Acute hypoxemic respiratory failure (AHRF), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2020; status: completed.
02
Drugs
almitrine
03
Conditions
coronavirus disease 2019 (COVID-19)Acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT04357457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357457.